When thinking about medications (GLP-1 or others) we consider other medical conditions, other symptoms and what medication interactions might be an issue
Those with a long half-life (weekly exenatide, efpeglenatide, liraglutide, semaglutide, albiglutide and dulaglutide) produce a sustained activation of rGLP1, resulting in a greater reduction in HbA1c, basal glycemia and body weight and would have fewer gastrointestinal side effects
Sep 15, 2025 1 GLP-1 Access: September Newsletter Updates for 2 GLP-1 Meetups, Serena Williams on a GLP-1, and a Freebie
If you have Type 1 diabetes or advanced Type 2 diabetes with severely depleted beta cells, GLP-1 agonists alone will not adequately control your blood sugar
These drugs are becoming more common
Accessibility of Weight Loss Drugs Making weight loss drugs accessible is a goal for many, but insurance coverage plays a big role